Official SEC submissions

Recursion Pharmaceuticals SEC Filings

Recursion Pharmaceuticals (RXRX) SEC filings, periodic reports and insider subm…

Direct answer

Recursion Pharmaceuticals's latest SEC filing is 144.

It was filed on August 21, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Recursion Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

Verified data

Recent filing categories
4
Recent filings
40
SEC CIK
0001601830
Latest filing date
August 21, 2026

Explore related company data

View the Recursion Pharmaceuticals company profileView Recursion Pharmaceuticals annual financials